Edition:
United Kingdom

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

2.20USD
5:36pm GMT
Change (% chg)

$-0.21 (-8.71%)
Prev Close
$2.41
Open
$2.45
Day's High
$2.46
Day's Low
$2.20
Volume
23,907
Avg. Vol
21,211
52-wk High
$16.65
52-wk Low
$1.41

Chart for

About

Proteostasis Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in discovery and development of therapeutics that treat diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. It has developed the Disease Relevant... (more)

Overall

Beta: --
Market Cap(Mil.): $55.48
Shares Outstanding(Mil.): 25.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Proteostasis Therapeutics Q3 loss per share $0.56

* Proteostasis Therapeutics reports third quarter 2017 results and provides CF portfolio update

14 Nov 2017

BRIEF-Proteostasis Therapeutics to prioritize resources on cystic fibrosis R&D

* Proteostasis Therapeutics - ‍initiated strategic prioritization to focus resources on research & development of cystic fibrosis programs, among others​

31 Oct 2017

BRIEF-Proteostasis Therapeutics appoints Helen Boudreau as CFO

* Proteostasis appoints Helen Boudreau as chief financial officer

31 Jul 2017

Earnings vs. Estimates